Healius Ltd (ASX: HLS) Share Price and News

Price

$0.805

Movement

0.015 (-1.83%)

As at 16 Jun - Closed (20 mins delayed)

52 Week Range

$0.81 - $1.86

 
1 Year Return

-44.1%

Healius Ltd Chart and Price Data

2025
2025
2025
2025
$0
$1
$2
$0
$1
$2
$0
$1
$2
$0
$1
$2

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $595.43 million
P/E Ratio 55.56
Dividend Yield 0.00%
Shares Outstanding 726.13 million
Earnings per share -0.964
Dividend per share 0.12
Year To Date Return -8.54%
Earnings Yield 1.80%
Franking 100%
Earnings Yield

1.80%

Franking

100%

Dividend per share

0.12

Year To Date Return

-8.54%

Shares Outstanding

726.13 million

Earnings per share

-0.964

Share Price

$0.805

Day Change

0.015 (-1.83%)

52 Week Range

$0.81 - $1.86

Yesterday's Close

$0.82

Today's Open

$0.82

Days Range

$0.805 - $0.83

Volume

3,143,464

Avg. Volume (1 month)

7,008,048

Turnover

$2,566,781

As at 16 Jun - Closed

  • Healius Ltd (ASX: HLS)
    Latest News

    Two brokers pointing and analysing a share price.
    Share Market News

    Here are the ASX 20, ASX 50, ASX 100, and ASX 200 shares being added and kicked out of their indices

    Let's see what changes are being made at this month's quarterly rebalance.

    Read more »

    Happy man working on his laptop.
    Share Market News

    5 things to watch on the ASX 200 on Tuesday

    Here's what to watch on the benchmark index today.

    Read more »

    Red sell button on an Apple keyboard.
    Broker Notes

    Sell alert! Brokers say pull the plug on these 3 ASX 200 shares

    Experts say it's time to press the sell button on these ASX 200 shares. Find out why.

    Read more »

    a woman holds her hands to her temples as she sits in front of a computer screen with a concerned look on her face.
    Share Fallers

    The 5 worst performing ASX 200 shares in May unmasked

    These five ASX 200 shares got smashed in May. But why?

    Read more »

    Cropped shot of an attractive young female scientist working on her computer in the laboratory.
    Healthcare Shares

    Why Macquarie forecasts 30-50% upside for these ASX All Ords healthcare stocks

    Macquarie updated its target price on these three ASX All Ords healthcare stocks.

    Read more »

    A man looks down with fright as he falls towards the ground.
    Share Fallers

    Why Aspen, Healius, Nufarm, and Propel shares are falling today

    These shares are having a tough session on Tuesday. But why?

    Read more »

    A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
    Share Fallers

    Why Healius, Light & Wonder, REA Group, and Regis Resources shares are falling today

    These shares are ending the week in the red. Let's find out why.

    Read more »

    A man holds his head in his hands, despairing at the bad result he's reading on his computer.
    Healthcare Shares

    Why is this ASX 200 stock crashing 30% today?

    What's going with this stock? Let's find out why its shares are deep in the red.

    Read more »

    A close-up photo of a ballot box with an Australian flag in front of it and a gentleman's hands placing his vote in the 2022 election inside the box
    Share Market News

    How these ASX 200 stocks are primed to gain from Labor's resounding Federal election win

    With the Federal election in the rear-view, which ASX 200 stocks should I buy now?

    Read more »

    Man holding fifty Australian Dollar banknote in his hands, symbolising dividends, symbolising dividends.
    Dividend Investing

    This ASX 200 stock is planning to pay a 25% dividend yield this month

    This stock is rewarding its shareholders handsomely. Here's what is happening.

    Read more »

    A neon sign says 'Top Ten'.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was a rough trading day for ASX stocks this Monday.

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    It was the ASX's fourth day of gains for the week today.

    Read more »

    Frequently Asked Questions

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    09 May 2025 $0.4130 100.00% Special Cash 23 May 2025
    07 Sep 2022 $0.0600 100.00% Final 21 Sep 2022
    24 Mar 2022 $0.1000 100.00% Interim 05 Apr 2022
    13 Sep 2021 $0.0675 100.00% Final 08 Oct 2021
    25 Mar 2021 $0.0650 100.00% Interim 15 Apr 2021
    26 Mar 2020 $0.0260 100.00% Interim 15 Oct 2020
    29 Aug 2019 $0.0340 100.00% Final 27 Sep 2019
    15 Mar 2019 $0.0380 100.00% Interim 26 Mar 2019
    27 Aug 2018 $0.0550 100.00% Final 17 Sep 2018
    16 Mar 2018 $0.0510 100.00% Interim 27 Mar 2018
    31 Aug 2017 $0.0000 100.00% Final 18 Sep 2017
    17 Mar 2017 $0.0480 100.00% Interim 28 Mar 2017
    01 Sep 2016 $0.0640 100.00% Final 19 Sep 2016
    18 Mar 2016 $0.0560 50.00% Interim 29 Mar 2016
    26 Aug 2015 $0.1100 50.00% Final 14 Sep 2015
    18 Mar 2015 $0.0900 100.00% Interim 07 Apr 2015
    27 Aug 2014 $0.1100 100.00% Final 15 Sep 2014
    17 Mar 2014 $0.0900 100.00% Interim 07 Apr 2014
    16 Sep 2013 $0.1100 100.00% Final 08 Oct 2013
    18 Mar 2013 $0.0650 100.00% Interim 08 Apr 2013
    17 Sep 2012 $0.0600 100.00% Final 08 Oct 2012
    26 Mar 2012 $0.0500 100.00% Interim 16 Apr 2012
    19 Sep 2011 $0.0500 100.00% Final 10 Oct 2011
    21 Mar 2011 $0.0300 100.00% Interim 11 Apr 2011
    20 Sep 2010 $0.1000 100.00% Final 11 Oct 2010
    05 Mar 2010 $0.1500 100.00% Interim 29 Mar 2010
    07 Sep 2009 $0.0700 100.00% Final 28 Sep 2009
    16 Feb 2009 $0.0700 100.00% Interim 09 Mar 2009
    08 Sep 2008 $0.0500 100.00% Final 09 Oct 2008
    22 Feb 2008 $0.2200 100.00% Interim 17 Mar 2008
    31 Aug 2007 $0.2400 100.00% Final 24 Sep 2007
    09 Mar 2007 $0.2100 100.00% Interim 02 Apr 2007
    09 Oct 2006 $0.0800 100.00% Special Cash 30 Oct 2006
    04 Sep 2006 $0.2200 100.00% Final 25 Sep 2006
    20 Feb 2006 $0.2000 100.00% Interim 13 Mar 2006
    22 Aug 2005 $0.1300 100.00% Final 12 Sep 2005
    08 Apr 2004 $0.0750 100.00% Interim 03 May 2004

    HLS ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    16th Jun 2025 2025-06-16T18:36:18 Change in substantial holdingYesNo6:36pm8425k
    12th Jun 2025 2025-06-12T12:27:25 Change in substantial holdingYesNo12:27pm51.6M
    6th Jun 2025 2025-06-06T17:01:58 S&P DJI Announces June 2025 Quarterly RebalanceYesNo5:01pm393k
    29th May 2025 2025-05-29T17:14:12 Ceasing to be a substantial holder from PPTYesNo5:14pm5540k
    29th May 2025 2025-05-29T16:30:47 Appointment of Company SecretaryYesNo4:30pm175k
    21st May 2025 2025-05-21T16:19:25 Change in substantial holdingYesNo4:19pm26825k
    14th May 2025 2025-05-14T16:33:39 Change in substantial holding from PPTYesNo4:33pm8603k
    9th May 2025 2025-05-09T16:28:33 Change in substantial holdingYesNo4:28pm6261k
    5th May 2025 2025-05-05T13:55:01 Dividend/Distribution - HLSYesNo1:55pm414k
    5th May 2025 2025-05-05T13:45:01 Fully Franked Special Dividend of 41.3 cents per shareYesNo1:45pm1149k

    About Healius Ltd

    Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.

    The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres. 

    The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics. 

    HLS Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Jun 2025 $0.82 $-0.02 -2.40% 3,798,453 $0.83 $0.85 $0.82
    12 Jun 2025 $0.84 $-0.01 -1.19% 3,867,418 $0.84 $0.85 $0.82
    11 Jun 2025 $0.84 $0.02 2.44% 6,275,858 $0.84 $0.87 $0.82
    10 Jun 2025 $0.82 $-0.01 -1.20% 12,555,235 $0.83 $0.84 $0.81
    06 Jun 2025 $0.83 $0.00 0.00% 39,311,994 $0.84 $0.84 $0.81
    05 Jun 2025 $0.83 $-0.04 -4.60% 6,174,752 $0.87 $0.88 $0.83
    04 Jun 2025 $0.87 $0.01 1.16% 4,190,034 $0.87 $0.90 $0.87
    03 Jun 2025 $0.87 $-0.01 -1.14% 4,334,262 $0.88 $0.89 $0.85
    02 Jun 2025 $0.88 $0.00 0.00% 5,417,831 $0.87 $0.89 $0.86
    30 May 2025 $0.88 $-0.01 -1.14% 6,175,994 $0.88 $0.90 $0.86
    29 May 2025 $0.88 $-0.03 -3.31% 13,024,181 $0.91 $0.94 $0.87
    28 May 2025 $0.91 $0.02 2.26% 8,176,189 $0.90 $0.96 $0.89
    27 May 2025 $0.89 $-0.07 -7.33% 4,883,516 $0.95 $0.95 $0.88
    26 May 2025 $0.96 $-0.02 -2.05% 3,326,623 $0.98 $0.98 $0.95
    23 May 2025 $0.98 $-0.02 -2.01% 6,898,100 $1.00 $1.02 $0.97
    22 May 2025 $1.00 $-0.05 -4.81% 3,134,697 $1.03 $1.03 $1.00
    21 May 2025 $1.04 $-0.02 -1.89% 2,084,766 $1.07 $1.07 $1.03
    20 May 2025 $1.06 $0.00 0.00% 1,996,050 $1.06 $1.07 $1.05
    19 May 2025 $1.07 $-0.02 -1.85% 1,923,086 $1.08 $1.09 $1.05
    16 May 2025 $1.08 $0.01 0.93% 2,611,929 $1.08 $1.10 $1.07

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    21 Nov 2024 Michael Stanford Buy 40,000 $53,200
    On-market trade.
    21 Nov 2024 Sally Evans Buy 30,418 $39,847
    On-market trade.
    20 Nov 2024 Paul Anderson Buy 37,837 $48,052
    On-market trade.
    20 Nov 2024 Kathryn (Kate) McKenzie Buy 40,000 $52,000
    On-market trade.
    27 Aug 2024 Sally Evans Buy 16,450 $25,000
    Conversion of securities. VWAP
    27 Aug 2024 Sally Evans Exercise 16,450 $25,000
    Conversion of securities. VWAP
    27 Aug 2024 Charlie Taylor Exercise 16,450 $25,000
    Conversion of securities. VWAP
    27 Aug 2024 Charlie Taylor Buy 16,450 $25,000
    Conversion of securities. VWAP

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Michael Philip Stanford Non-Executive Director Sep 2023
    Dr Stanford is a member of the People & Governance Committees. Michael has over 20 years of experience as a Chief Executive Officer and Managing Director of multi-campus and multi-service health care organisations with national and international areas of operation, including St John of God Health Care, Australian Hospital Care Ltd, North-Western Health, North-Eastern Health Care Network and Austin & Repatriation Medical Centre.
    Professor John Mattick Non-Executive Director Mar 2022
    Professor Mattick is a member of the Risk Management Committees. John is a Professor in the School of Biotechnology and Biomolecular Science at UNSW Sydney. He was Chief Executive of Genomics England and Executive Director of the Garvan Institute of Medical Research. He was a member of the Australian Health Ethics Committee of the National Health & Medical Research Council, an advisor to the Australian Law Reform Commission's Inquiry into the Protection of Human Genetic Information and Gene Patenting & Human Health.
    Mr Paul Anderson Chief Executive OfficerManaging Director Mar 2024
    Mr Anderson has background in industries facing disruption. He was previously Chief Executive Officer of Network Ten and more recently, Executive Vice President at Viacom CBS Networks Australia & NZ. He also spent more than a decade working abroad at CLS Holdings plc in London and KPMG in New Zealand.
    Ms Kathryn (Kate) Mary McKenzie Non-Executive ChairmanNon-Executive Director Feb 2021
    Ms McKenzie is Chair of the Risk Committee and a member of the People & Governance Committee. Kate has corporate governance experience and has held several executive roles, including CEO of Chorus Limited (NZ) and COO of Telstra. She also held the roles of CEO of the NSW Department of Commerce and CEO of WorkCover. She is on the Board of Stockland and Chair of nbnco.
    Ms Sally Evans Non-Executive Director Aug 2018
    Ms Evans is Chair of the People & Governance Committee and a member of the Risk Management Committee. Sally has over 30 years of experience in private, government and social enterprise sectors and has worked in Australia, New Zealand, the United Kingdom, and Hong Kong with responsibilities across the broader Asia Pacific region. She is a board member of Allianz Australia Life, Oceania Healthcare (NZ) and Ingenia Communities.
    Ms Katherine (Kathy) Ostin Non-Executive Director Dec 2024
    Ms Ostin was an Audit, Assurance and Risk Consulting Partner at KPMG from 2005 to 2017 and has experience in the aged care and healthcare sectors, having established and led KPMGs Health, Aging and Human Services audit practice from 2006 to 2018. During her 24 years with KPMG, Ms Ostin worked in Australia, the US, Asia and UK. Ms Ostins other current ASX board and audit chair roles include for 3P Learning Limited (ASX:3PL) as a Non-Executive Director and Chair of Audit & Risk Committee, Capral Limited (ASX:CAP) as a Non Executive Director and Chair of Audit & Risk Committee, dusk Group Limited (ASX:DSK) as a Non Executive Director and Chair of Audit & Risk Committee, Elanor Investors Group (ASX:ENN) and Elanor Commercial Property Fund (ASX:ECF) as a Non-Executive Director and Next Science Limited (ASX:NXS) as a Non-Executive Director and Chair of Audit & Risk Committee.
    Mr Charlie Taylor Non-Executive Director Mar 2023
    Mr Taylor has over 30 years of experience in international advisory firms, including as Senior Partner at McKinsey where he led the Health and Public Sector practices. He has advised many of Australia's private and public sector healthcare organisations and initiated multi-year research efforts on healthcare, Covid response, productivity, and innovation. He is also a member of People & Governance Committee.
    Mr Neil Vinson Non-Executive Director Mar 2025
    --
    Mr Stephen Humphries Company Secretary Mar 2023
    -
    Ms Kylie Brown Company Secretary May 2025
    -
    Steve Humphries Chief Financial Officer
    -
    Stephen Humphries Company Secretary
    -
    Kylie Brown Company Secretary
    -
    Prasad Arav Group Executive Digital & Technology and Strategy
    -
    Phil Lucas Group Executive Lumus Imaging
    -
    Paula Bayliss Group Executive People & Culture
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 211,636,287 29.15%
    Citicorp Nominees Pty Limited 209,962,638 28.92%
    J P Morgan Nominees Australia Pty Limited 127,569,782 17.57%
    Argo Investments Limited 22,874,452 3.15%
    BNP Paribas Noms Pty Ltd 19,666,305 2.71%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 12,096,389 1.67%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 5,855,473 0.81%
    Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 4,335,651 0.60%
    National Nominees Limited 3,718,898 0.51%
    First Samuel Ltd Acn 086243567 <Anf Its Mda Clients A/C> 3,469,215 0.48%
    Rinrim Pty Ltd 2,497,161 0.34%
    HSBC Custody Nominees (Australia) Limited i 2,037,242 0.28%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 939,397 0.12%
    HSBC Custody Nominees (Australia) Limited <Gsco Customers A/C> 838,693 0.12%
    Netwealth Investments Limited <Wrap Services A/C> 731,765 0.10%
    Joromada Pty Ltd 660,000 0.09%
    Buttonwood Nominees Pty Ltd 658,941 0.09%
    Sep Super Pty Ltd <Sep Super Fund A/C> 637,236 0.09%
    Mr Gregory Anthony Thomas Bateman 636,213 0.08%
    Ioof Investment Services Limited <Ips Superfund A/C> 609,635 0.08%

    Profile

    since

    Note